K. H. Kim et al. / Tetrahedron Letters 53 (2012) 2761–2764
2763
O
Pd(OAc)2
O
O
1a
H
OPiv
Pd
PivOH
CsOPiv
2 Ag0
O
O
2 AcOH
H
Pd(OPiv)2
O
I
2 AgOAc
2 PivOH
PivOH
O
Pd0
O
Pd(OPiv)
II
O
O
O
2a
Ph
PivOH
O
III
Pd
Scheme 2.
O
O
3. Pd-catalyzed 3-arylation of chromones to isoflavones was carried out most
frequently by Suzuki–Miyaura coupling between 3-halochromones and
arylboronic acids, see: (a) Gavande, N.; Karim, N.; Johnston, G. A. R.;
Hanrahan, J. R.; Chebib, M. ChemMedChem 2011, 6, 1340–1346; (b) Wei, G.;
Yu, B. Eur. J. Org. Chem. 2008, 3156–3163; (c) Eisnor, C. R.; Gossage, R. A.; Yadav,
P. N. Tetrahedron 2006, 62, 3395–3401; (d) Yokoe, I.; Sugita, Y.; Shirataki, Y.
Chem. Pharm. Bull. 1989, 37, 529–530; (e) Hoshino, Y.; Miyaura, N.; Suzuki, A.
Bull. Chem. Soc. Jpn. 1988, 61, 3008–3010; (f) Zheng, S.-Y.; Shen, Z.-W.
Tetrahedron Lett. 2010, 51, 2883–2887. Pd-catalyzed 2-arylation of
chromones was carried out by the coupling reaction between 2-
chlorochromones and arylboronic acids, see:; (g) Kraus, G. A.; Gupta, V. Org.
Lett. 2010, 12, 5278–5280.
D
D
same conditions
benzene (30 equiv)
benzene-d6 (30 equiv)
D
D
2a +
1a
+
D
2a-d5
2a/2a-d5 = kH/kD = 5.8
Scheme 3.
4. Khoobi, M.; Alipour, M.; Zarei, S.; Jafarpour, F.; Shafiee, A. Chem. Commun. 2012,
48, 2985–2987.
bromobenzene (2.0 equiv)
Pd(OAc)2 (10 mol%), PPh3 (20 mol%)
5. (a) Cho, S. H.; Kim, J. Y.; Kwak, J.; Chang, S. Chem. Soc. Rev. 2011, 40, 5068–5083;
(b) Ackermann, L.; Vicente, R.; Kapdi, A. R. Angew. Chem., Int. Ed. 2009, 48,
9792–9826; (c) Dwight, T. A.; Rue, N. R.; Charyk, D.; Josselyn, R.; DeBoef, B. Org.
Lett. 2007, 9, 3137–3139; (d) Malakar, C. C.; Schmidt, D.; Conrad, J.; Beifuss, U.
Org. Lett. 2011, 13, 1378–1381; (e) Xi, P.; Yang, F.; Qin, S.; Zhao, D.; Lan, J.; Gao,
G.; Hu, C.; You, J. J. Am. Chem. Soc. 2010, 132, 1822–1824; (f) Bugaut, X.; Glorius,
F. Angew. Chem., Int. Ed. 2011, 50, 7479–7481; (g) He, C.-Y.; Fan, S.; Zhang, X. J.
Am. Chem. Soc. 2010, 132, 12850–12852.
+
2a (12%)
3a (24%)
1a
K2CO3 (3.0 equiv), PivOH (30 mol%)
DMF, 120 oC, 12 h
Scheme 4.
6. (a) Kim, K. H.; Lee, H. S.; Kim, J. N. Tetrahedron Lett. 2011, 52, 6228–6233; (b)
Kim, K. H.; Lee, H. S.; Kim, S. H.; Kim, J. N. Tetrahedron Lett. 2012, 53, 1323–
1327.
Acknowledgments
7. Cesium pivalate may interact with Pd(OAc)2 to generate Pd(OPiv)2 more
efficiently, see: (a) Stuart, D. R.; Fagnou, K. Science 2007, 316, 1172–1175; (b)
Liegault, B.; Lapointe, D.; Caron, L.; Vlassova, A.; Fagnou, K. J. Org. Chem. 2009,
74, 1826–1834.
This work was supported by the National Research Foundation
of Korea Grant funded by the Korean Government (2011-0002570).
Spectroscopic data were obtained from the Korea Basic Science
Institute, Gwangju branch.
8. Typical procedure for the synthesis of 2a: A stirred mixture of chromone (1a,
73 mg, 0.5 mmol), Pd(OAc)2 (6 mg, 5 mol %), AgOAc (251 mg, 1.5 mmol), PivOH
(306 mg, 3.0 mmol), and CsOPiv (23 mg, 0.1 mmol) in benzene (2.7 mL,
60 equiv) was heated to reflux for 12 h under nitrogen atmosphere. After
cooling to room temperature, the crude reaction mixture was filtered over a
pad of Celite and washed with CH2Cl2. The solvent was removed and the
residue was dissolved in EtOAc (150 mL) and washed with a saturated solution
of NaHCO3 (20 mL ꢀ 3). The combined organic layers were dried over MgSO4
and concentrated under vacuum. The residue was purified by column
chromatography (hexanes/EtOAc, 10:1) to afford 2a (76 mg, 68%) as a pale
yellow solid along with a trace amount of 3a (4 mg, 4%).3e Other compounds
were synthesized similarly, and the selected spectroscopic data of unknown
compounds 2b–d, 2f, 2g, 2i and 2j are as follows. The compounds 2a,2c 2e,2a
2f0,2l 2h1b are known, and the spectroscopic data are same with the reported.
Compound 2b: 71%; pale yellow solid, mp 130–131 oC; IR (KBr) 1642, 1567,
References and notes
1. For the biological activities of flavones and related compounds, see: (a)
Middleton, E., Jr.; Kandaswami, C.; Theoharides, T. C. Pharmacol. Rev. 2000, 52,
673–751. and further references cited therein; (b) Kahnberg, P.; Lager, E.;
Rosenberg, C.; Schougaard, J.; Camet, L.; Sterner, O.; Nielsen, E. O.; Nielsen, M.;
Liljefors, T. J. Med. Chem. 2002, 45, 4188–4201; (c) Fujita, Y.; Yonehara, M.;
Tetsuhashi, M.; Noguchi-Yachide, T.; Hashimoto, Y.; Ishikawa, M. Bioorg. Med.
Chem. 2010, 18, 1194–1203; (d) Eleya, N.; Malik, I.; Reimann, S.; Wittler, K.;
Hein, M.; Patonay, T.; Villinger, A.; Ludwig, R.; Langer, P. Eur. J. Org. Chem. 2012,
1639–1652.
2. For the general synthetic approaches of flavones, see: (a) Du, Z.; Ng, H.; Zhang,
K.; Zeng, H.; Wang, J. Org. Biomol. Chem. 2011, 9, 6930–6933; (b) Chee, C. F.;
Buckle, M. J. C.; Rahman, N. A. Tetrahedron Lett. 2011, 52, 3120–3123; (c) Maiti,
G.; Karmakar, R.; Bhattacharya, R. N.; Kayal, U. Tetrahedron Lett. 2011, 52, 5610–
5612; (d) Zhao, J.; Zhao, Y.; Fu, H. Angew. Chem., Int. Ed. 2011, 50, 3769–3773;
(e) Yoshida, M.; Fujino, Y.; Doi, T. Org. Lett. 2011, 13, 4526–4529; (f) Xue, L.; Shi,
L.; Han, Y.; Xia, C.; Huynh, H. V.; Li, F. Dalton Trans. 2011, 40, 7632–7638; (g)
Lorenz, M.; Kabir, M. S.; Cook, J. M. Tetrahedron Lett. 2010, 51, 1095–1098; (h)
Shimizu, M.; Tsurugi, H.; Satoh, T.; Miura, M. Chem. Asian J. 2008, 3, 881–886;
(i) Kumar, K. H.; Perumal, P. T. Tetrahedron 2007, 63, 9531–9535; (j) Ganguly, A.
K.; Mahata, P. K.; Biswas, D. Tetrahedron Lett. 2006, 47, 1347–1349; (k) Kabalka,
G. W.; Mereddy, A. R. Tetrahedron Lett. 2005, 46, 6315–6317; (l) Huang, X.;
Tang, E.; Xu, W.-M.; Cao, J. J. Comb. Chem. 2005, 7, 802–805.
1467, 1367 cmꢁ1 1H NMR (CDCl3, 300 MHz) d 2.41 (s, 6H), 6.79 (s, 1H), 7.17 (s,
;
1H), 7.41 (ddd, J = 8.1, 6.9 and 0.9 Hz, 1H), 7.53 (s, 2H), 7.58 (dd, J = 8.4 and
0.9 Hz, 1H), 7.69 (ddd, J = 8.4, 6.9 and 1.8 Hz, 1H), 8.23 (dd, J = 8.1 and 1.8 Hz,
1H); 13C NMR (CDCl3, 75 MHz) d 21.33, 107.45, 118.05, 123.95, 124.06, 125.08,
125.62, 131.65, 133.30, 133.61, 138.66, 156.25, 163.80, 178.44; ESIMS m/z 251
[M+H]+. Anal. Calcd for C17H14O2: C, 81.58; H, 5.64. Found: C, 81.39; H, 5.81.
Compound 2c: 66%; pale yellow solid, mp 116–117 oC; IR (KBr) 1640, 1568,
1467, 1366 cmꢁ1 1H NMR (CDCl3, 300 MHz) d 2.34 (s, 3H), 2.36 (s, 3H), 6.79 (s,
;
1H), 7.27 (d, J = 7.5 Hz, 1H), 7.41 (ddd, J = 8.1, 6.9 and 1.2 Hz, 1H), 7.55–7.59 (m,
1H), 7.63–7.72 (m, 3H), 8.23 (dd, J = 8.1 and 1.8 Hz, 1H); 13C NMR (CDCl3,
75 MHz) d 19.88, 19.92, 106.91, 118.03, 123.82, 123.98, 125.05, 125.63, 127.27,
129.26, 130.28, 133.57, 137.41, 140.97, 156.24, 163.77, 178.46; ESIMS m/z 251